Brief: Clarity Pharmaceuticals Confirms No Supply Interruptions
02/03/2023 06:05
March 2 (Reuters) - Clarity Pharmaceuticals Ltd
CU6.AX :
* NOTES RECENT SUPPLY INTERRUPTION FOR NOVARTIS' PLUVICTO
RADIOTHERAPY
* CLARITY'S TARGETED COPPER THERANOSTICS PRODUCTS AND
CLINICAL
DEVELOPMENT PROGRAMS ARE UNAFFECTED
Source text for Eikon: ID:nASX6QqFW7
Further company coverage: CU6.AX
((reuters.briefs@thomsonreuters.com;))
Recent news on Clarity Pharmaceuticals
See all newsBrief: Clarity Pharmaceuticals Signs Commercial Manufacturing Agreement
Brief: Clarity Signs A Large-Scale Manufacturing Supply Agreement For Copper-64 With Theragenics
Brief: Clarity Pharmaceuticals Signs A Large-Scale Manufacturing Supply Agreement
Australia's Clarity Pharmaceuticals rises on bagging cancer detection agent supply
Australia's Clarity Pharma surges as US FDA approves trial